Bison Wealth’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bison Wealth’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$196K	–	238
2018 Q3	$196K	Sell	10,000 -16,179	-62%	-$308K	0.13%	212
2018 Q2	$434K	Sell	26,179 -1,450	-5%	-$22.1K	0.32%	94
2018 Q1	$392K	Buy	27,629 +1,140	+4%	+$16.8K	0.3%	103
2017 Q4	$387K	Sell	26,489 -2,618	-9%	-$36.8K	0.28%	96
2017 Q3	$369K	Sell	29,107 -551	-2%	-$7.01K	0.3%	96
2017 Q2	$352K	Sell	29,658 -116	-0.4%	-$1.44K	0.29%	96
2017 Q1	$440K	Buy	29,774 +2,466	+9%	+$39.9K	0.38%	74
2016 Q4	$442K	Sell	27,308 -2,237	-8%	-$40.6K	0.38%	70
2016 Q3	$536K	Sell	29,545 -3,803	-11%	-$74.3K	0.45%	69
2016 Q2	$549K	Buy	33,348 +5,906	+22%	+$95.6K	0.33%	93
2016 Q1	$455K	Sell	27,442 -4,276	-13%	-$74.8K	0.29%	105
2015 Q4	$687K	Buy	31,718 +310	+1%	+$6.03K	0.39%	82
2015 Q3	$623K	Buy	+31,408	New	+$992K	0.41%	78

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bison Wealth's HZNP Position: Q4 2018 in Review

Bison Wealth sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2018, closing a stake of 10,000 shares — an estimated $196K sold.

Bison Wealth first reported a position in HZNP in Q3 2015 and held it in 13 quarters. The position peaked at $687K in Q4 2015. 239 funds tracked by Wall St. Rank hold HZNP as of Q4 2018.

Bison Wealth reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2018 after selling out during the quarter.
Bison Wealth sold 10,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2018, an estimated $196K.
Bison Wealth first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 13 quarters.
Bison Wealth's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $687K in Q4 2015.
239 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2018.

Based on Bison Wealth's 13F filing for Q4 2018, filed 8 Feb 2019.